New study aims to stop muscle loss in popular Weight-Loss drug users
NCT ID NCT07554417
First seen May 02, 2026 · Last updated May 02, 2026
Summary
This study tests whether a 12-week program of exercise and personalized diet advice can help adults aged 40-55 with obesity keep their muscle while taking GLP-1 weight-loss drugs like semaglutide. About 20 participants will be followed to see if their muscle mass and bone density stay stable. The goal is to make weight loss safer and more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE LOSS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Rice University
Houston, Texas, 77005, United States
Conditions
Explore the condition pages connected to this study.